Page last updated: 2024-10-25

deferoxamine and Cryoglobulinemia

deferoxamine has been researched along with Cryoglobulinemia in 1 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Cryoglobulinemia: A condition characterized by the presence of abnormal quantities of CRYOGLOBULINS in the blood. Upon cold exposure, these abnormal proteins precipitate into the microvasculature leading to restricted blood flow in the exposed areas.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Biliotti, E1
Palazzo, D1
Serani, M1
Silvestri, AM1
Volpicelli, L1
Esvan, R1
Franchi, C1
Spaziante, M1
Sorrentino, F1
Taliani, G1

Other Studies

1 other study available for deferoxamine and Cryoglobulinemia

ArticleYear
Interferon free antiviral treatment of chronic hepatitis C in patients affected by β-thalassemia major.
    Annals of hematology, 2017, Volume: 96, Issue:6

    Topics: Adult; Antiviral Agents; Benzimidazoles; Benzoates; beta-Thalassemia; Cryoglobulinemia; Deferasirox;

2017